309 related articles for article (PubMed ID: 35484367)
1. Integrating Management of Hepatitis C Infection into Primary Care: the Key to Hepatitis C Elimination Efforts.
Wang AE; Hsieh E; Turner BJ; Terrault N
J Gen Intern Med; 2022 Oct; 37(13):3435-3443. PubMed ID: 35484367
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C Virus in Pregnancy: An Opportunity to Test and Treat.
Fogel RS; Chappell CA
Obstet Gynecol Clin North Am; 2023 Jun; 50(2):363-373. PubMed ID: 37149316
[TBL] [Abstract][Full Text] [Related]
3. Liver function tests in primary care provide a key opportunity to diagnose and engage patients with hepatitis C.
McLeod A; Hutchinson SJ; Weir A; Barclay S; Schofield J; Frew CG; Goldberg DJ; Heydtmann M; Wilson-Davies E
Epidemiol Infect; 2022 Jun; 150():e133. PubMed ID: 35757860
[TBL] [Abstract][Full Text] [Related]
4. Elimination of HCV in Russia: Barriers and Perspective.
Isakov V; Nikityuk D
Viruses; 2022 Apr; 14(4):. PubMed ID: 35458520
[TBL] [Abstract][Full Text] [Related]
5. Patient and healthcare provider experiences of hepatitis C treatment with direct-acting antivirals in Rwanda: a qualitative exploration of barriers and facilitators.
Serumondo J; Penkunas MJ; Niyikora J; Ngwije A; Kiromera A; Musabeyezu E; Umutesi J; Umuraza S; Musengimana G; Nsanzimana S
BMC Public Health; 2020 Jun; 20(1):946. PubMed ID: 32546216
[TBL] [Abstract][Full Text] [Related]
6. Outreach onsite treatment with a simplified pangenotypic direct-acting anti-viral regimen for hepatitis C virus micro-elimination in a prison.
Chen CT; Lu MY; Hsieh MH; Tsai PC; Hsieh TY; Yeh ML; Huang CI; Tsai YS; Ko YM; Lin CC; Chen KY; Wei YJ; Hsu PY; Hsu CT; Jang TY; Liu TW; Liang PC; Hsieh MY; Lin ZY; Huang CF; Huang JF; Dai CY; Chuang WL; Shih YL; Yu ML
World J Gastroenterol; 2022 Jan; 28(2):263-274. PubMed ID: 35110949
[TBL] [Abstract][Full Text] [Related]
7. Planning the hepatitis C virus elimination in Cyprus: A modeling study.
Gountas I; Yiasemi I; Kyprianou E; Mina C; Georgiou C; Katsioloudes P; Kouroufexi A; Demetriou A; Xenofontos E; Nikolopoulos G
World J Gastroenterol; 2021 Aug; 27(31):5219-5231. PubMed ID: 34497446
[TBL] [Abstract][Full Text] [Related]
8. Universal screening for hepatitis C - in for a penny, in for a pound.
Garrido I; Macedo G
Eur J Clin Microbiol Infect Dis; 2022 Mar; 41(3):341-347. PubMed ID: 35022892
[TBL] [Abstract][Full Text] [Related]
9. Current hepatitis C therapy.
Husa P; Snopková S; Husa Ml P
Cas Lek Cesk; 2022; 161(2):90-93. PubMed ID: 35728965
[TBL] [Abstract][Full Text] [Related]
10. Evaluating hepatitis C cascade of care surveillance system in Tuscany, Italy, through a population retrospective data-linkage study, 2015-2021.
Ceccarelli L; Moretti G; Mazzilli S; Petri D; Corazza I; Rizzo C; Lucenteforte E; Vainieri M; Seghieri C; Tavoschi L;
BMC Infect Dis; 2024 Mar; 24(1):362. PubMed ID: 38553731
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the hepatitis C cascade of care among people living with HIV in New South Wales, Australia: A data linkage study.
Hosseini-Hooshyar S; Alavi M; Martinello M; Valerio H; Tillakeratne S; Matthews GV; Dore GJ
J Viral Hepat; 2022 Apr; 29(4):271-279. PubMed ID: 35175671
[TBL] [Abstract][Full Text] [Related]
12. Loss to follow-up in the hepatitis C care cascade: A substantial problem but opportunity for micro-elimination.
van Dijk M; Drenth JPH;
J Viral Hepat; 2020 Dec; 27(12):1270-1283. PubMed ID: 32964615
[TBL] [Abstract][Full Text] [Related]
13. Treatment access is only the first step to hepatitis C elimination: experience of universal anti-viral treatment access in Australia.
Doyle JS; Scott N; Sacks-Davis R; Pedrana AE; Thompson AJ; Hellard ME;
Aliment Pharmacol Ther; 2019 May; 49(9):1223-1229. PubMed ID: 30908706
[TBL] [Abstract][Full Text] [Related]
14. Brief Report: HCV Universal Test-and-Treat With Direct Acting Antivirals for Prisoners With or Without HIV: A Prison Health Care Workers-Led Model for HCV Microelimination in Thailand.
Supanan R; Han WM; Harnpariphan W; Ueaphongsukkit T; Ubolyam S; Sophonphan J; Tangkijvanich P; Thanprasertsuk S; Avihingsanon A;
J Acquir Immune Defic Syndr; 2021 Dec; 88(5):465-469. PubMed ID: 34757974
[TBL] [Abstract][Full Text] [Related]
15. Securing sustainable funding for viral hepatitis elimination plans.
Hatzakis A; Lazarus JV; Cholongitas E; Baptista-Leite R; Boucher C; Busoi CS; Deuffic-Burban S; Chhatwal J; Esmat G; Hutchinson S; Malliori MM; Maticic M; Mozalevskis A; Negro F; Papandreou GA; Papatheodoridis GV; Peck-Radosavljevic M; Razavi H; Reic T; Schatz E; Tozun N; Younossi Z; Manns MP
Liver Int; 2020 Feb; 40(2):260-270. PubMed ID: 31808281
[TBL] [Abstract][Full Text] [Related]
16. Three Years of Progress Toward Achieving Hepatitis C Elimination in the Country of Georgia, April 2015-March 2018.
Tsertsvadze T; Gamkrelidze A; Chkhartishvili N; Abutidze A; Sharvadze L; Kerashvili V; Butsashvili M; Metreveli D; Gvinjilia L; Shadaker S; Nasrullah M; Adamia E; Zeuzem S; Afdhal N; Arora S; Thornton K; Skaggs B; Kuchuloria T; Lagvilava M; Sergeenko D; Averhoff F
Clin Infect Dis; 2020 Aug; 71(5):1263-1268. PubMed ID: 31563938
[TBL] [Abstract][Full Text] [Related]
17. [Elimination of hepatitis C virus in Denmark].
Døssing A; Røge BT; Madsen LG; Laursen AL; Hansen JB; Bukh J; Weis N
Ugeskr Laeger; 2020 Feb; 182(9):. PubMed ID: 32138816
[TBL] [Abstract][Full Text] [Related]
18. Systematic review: economic evaluations of HCV screening in the direct-acting antivirals era.
Cortesi PA; Barca R; Giudicatti G; Mossini S; Ciaccio A; Iannazzo S; Micale M; Cesana G; Mantovani LG
Aliment Pharmacol Ther; 2019 May; 49(9):1126-1133. PubMed ID: 30843268
[TBL] [Abstract][Full Text] [Related]
19. Hospital-based screening outperforms primary care screening as a means of achieving hepatitis C virus micro-elimination.
Fernández-García CE; Gallego-Galiana J; Solís-Muñoz PA; Del Pozo-Maroto E; Domínguez-Alcón L; Tobar-Izquierdo M; Sáez A; Rodríguez de Cía J; Magaña-Sánchez A; Real-Martínez Y; García-Buey L; González-Moreno L; Caldas-Álvarez M; Cardeñoso-Domingo LM; González-Gamarra A; Salvador-Calvo A; González-Rodríguez Á; García-Monzón C
Infect Dis Now; 2024 Mar; 54(2):104855. PubMed ID: 38309646
[TBL] [Abstract][Full Text] [Related]
20. Liver Disease Screening and Hepatitis C Virus Elimination in Taiwan Rural Indigenous Townships: Village-By-Village Screening and Linking to Outreach Hepatology Care.
Tien HM; Cheng TC; Lien HC; Yang KF; Shy CG; Chen YL; Hsu NT; Lu SN; Wang JH
Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35328957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
